Expand LKFT Menu
LKFT MENU

LKFT Latest Press Releases

-- October 14, 2026 --

Lakefront Announces Sale of Preclinical CAR-T Programs to Armed Cell Therapeutics Globe Newswire 4:01 PM

-- October 8, 2026 --

Lakefront Receives Transparency Notification from Bank of America Globe Newswire 4:01 PM

-- September 22, 2026 --

Acquisition of Own Shares Globe Newswire 4:01 PM

-- September 8, 2026 --

Acquisition of Own Shares Globe Newswire 4:02 PM
Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference Globe Newswire 4:01 PM

-- August 24, 2026 --

Lakefront Receives Transparency Notification from Bank of America Globe Newswire 4:01 PM
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus Globe Newswire 4:01 PM

-- August 20, 2026 --

Keymed Biosciences Announces 2026 H1 Results and Business Updates PRNewswire 10:11 AM

-- August 12, 2026 --

Acquisition of Own Shares Globe Newswire 4:01 PM

-- August 10, 2026 --

Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update Globe Newswire 4:01 PM

-- July 13, 2026 --

Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi Globe Newswire 4:01 PM

-- June 29, 2026 --

Lakefront Receives Transparency Notification from Madison Avenue Partners Globe Newswire 4:01 PM

-- June 16, 2026 --

Acquisition of Own Shares Globe Newswire 4:01 PM

-- June 9, 2026 --

Lakefront Announces Initiation of EUR 50 Million Stock Repurchase Program Globe Newswire 4:01 PM

-- June 8, 2026 --

Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer Globe Newswire 4:01 PM

-- June 4, 2026 --

Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline Business Wire 4:15 PM
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE Globe Newswire 4:15 PM
Market Data Delayed 15 Minutes